EPS (Diluted) for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current diluted EPS (TTM) is $3.59. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$3.59
YoY change
-51.3%
5Y CAGR
+8.3%
Peak year (2024)
$7.64
Latest annual
$3.72
EPS (Diluted) history chart for Abbott Laboratories (ABT) from 1985 to 2025
EPS (Diluted) history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $3.72 | -51.3% | ||
| 2024 | $7.64 | +133.6% | ||
| 2023 | $3.27 | -16.4% | ||
| 2022 | $3.91 | -0.8% | ||
| 2021 | $3.94 | +57.6% | ||
| 2020 | $2.50 | +21.4% | ||
| 2019 | $2.06 | +53.7% | ||
| 2018 | $1.34 | +396.3% | ||
| 2017 | $0.27 | -71.3% | ||
| 2016 | $0.94 | -68.0% | ||
| 2015 | $2.94 | +96.0% | ||
| 2014 | $1.50 | -8.5% | ||
| 2013 | $1.64 | -56.3% | ||
| 2012 | $3.75 | +24.6% | ||
| 2011 | $3.01 | +1.3% | ||
| 2010 | $2.97 | -19.7% | ||
| 2009 | $3.70 | +18.2% | ||
| 2008 | $3.13 | +35.5% | ||
| 2007 | $2.31 | +106.2% | ||
| 2006 | $1.12 | -48.1% | ||
| 2005 | $2.16 | +4.9% | ||
| 2004 | $2.06 | +17.7% | ||
| 2003 | $1.75 | -1.7% | ||
| 2002 | $1.78 | +79.8% | ||
| 2001 | $0.99 | -44.4% | ||
| 2000 | $1.78 | +13.4% | ||
| 1999 | $1.57 | +5.4% | ||
| 1998 | $1.49 | +12.0% | ||
| 1997 | $1.33 | +11.8% | ||
| 1996 | $1.19 | +12.3% | ||
| 1995 | $1.06 | +14.0% | ||
| 1994 | $0.93 | +10.7% | ||
| 1993 | $0.84 | +13.5% | ||
| 1992 | $0.74 | +15.6% | ||
| 1991 | $0.64 | +14.3% | ||
| 1990 | $0.56 | +14.3% | ||
| 1989 | $0.49 | +16.7% | ||
| 1988 | $0.42 | +20.0% | ||
| 1987 | $0.35 | +20.7% | ||
| 1986 | $0.29 | +16.0% | ||
| 1985 | $0.25 | — |
EPS (Diluted) values are taken from Abbott Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Abbott Laboratories (ABT) diluted EPS totalled $3.72 – plunged 51.3% year-over-year.
Across 2020–2025 (5 years), Abbott Laboratories diluted EPS produced a CAGR of +8.3% – with the latest reading among the more recent periods of the dataset.
Abbott Laboratories diluted EPS plunged from $7.64 in 2024 to $3.72 in 2025, a 51.3% drawdown.
The dataset's maximum diluted EPS sits at $7.64 (2024); the minimum reading of $0.25 dates to 1985.
Abbott Laboratories (ABT) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
Abbott Laboratories EPS (Diluted) by Year
Abbott Laboratories EPS (Diluted) 2025: $3.72
Abbott Laboratories diluted EPS in 2025 was $3.72, plunged 51.3% below 2024.
Abbott Laboratories EPS (Diluted) 2024: $7.64
Abbott Laboratories diluted EPS in 2024 was $7.64, surged 133.6% from 2023. This figure represents the highest annual value in the available history.
Abbott Laboratories EPS (Diluted) 2023: $3.27
Abbott Laboratories diluted EPS in 2023 was $3.27, declined 16.4% below 2022.
Abbott Laboratories EPS (Diluted) 2022: $3.91
Abbott Laboratories diluted EPS in 2022 was $3.91, edged down 0.8% below 2021.
Abbott Laboratories EPS (Diluted) 2021: $3.94
Abbott Laboratories diluted EPS in 2021 was $3.94.
See more financial history for Abbott Laboratories (ABT).
Sector peers — EPS (Diluted)
Companies in the same sector as Abbott Laboratories, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Abbott Laboratories's diluted EPS?
- Latest reported diluted EPS for Abbott Laboratories (ABT) is $3.59 (period ending March 31, 2026).
How has Abbott Laboratories diluted EPS changed year-over-year?
- Abbott Laboratories (ABT) diluted EPS changed -51.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories diluted EPS?
- Abbott Laboratories (ABT) diluted EPS compound annual growth rate is +8.3% over the most recent 5 years available.
When did Abbott Laboratories diluted EPS hit its highest annual value?
- Abbott Laboratories diluted EPS reached its highest annual value of $7.64 in 2024.
What was Abbott Laboratories diluted EPS in 2024?
- Abbott Laboratories (ABT) diluted EPS in 2024 was $7.64.
What was Abbott Laboratories diluted EPS in 2025?
- Abbott Laboratories (ABT) diluted EPS in 2025 was $3.72.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.